Formation of oligonucleotide triplexes with selectively modified

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 2532, 536 253, C12Q 168, C07H 2104

Patent

active

054078016

ABSTRACT:
An oligonucleotide or analog thereof including a single cytidine residue at a selected position and having one or more cytidine residues which are 5-methyl substituted. The cytidine nucleus can be selectively transaminated to include an aminoalkyl or carboxyalkyl group as a linker for other functional groups which can be used to form DNA duplexes and triplexes.

REFERENCES:
patent: 5082935 (1992-01-01), Cruickshank
Viscidi, R. P. et al. Novel chemical method for the preparation of nucleic acids in nonisotopic hybridization (J. Clin. Microbiol. (Feb. 1986) 23:311-317).
Ito, T., et al. Sequence-specific DNA purification by triplex affinity capture. (Proc. Natl. Acad. Sci. USA (Jan. 1992) 89:495-498.
Maher III, L. J., et al., Inhibition of DNA Binding Proteins by Oligonucleotide-Directed Triple Helix Formation. Science (Aug. 18, 1989) 245:725-730.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Formation of oligonucleotide triplexes with selectively modified does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formation of oligonucleotide triplexes with selectively modified, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formation of oligonucleotide triplexes with selectively modified will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-66151

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.